Microsoft and Seattle’s Adaptive Biotechnologies are seeking 1,000 people across the country for a “virtual clinical study” designed to better… Read More
Microsoft and Seattle-based Adaptive Biotechnologies announced Friday they will work together to map the immune response to COVID-19. The goal… Read More
Adaptive Biotechnologies‘ stock fell 7 percent Tuesday after the company posted larger-than-expected losses during the first quarterly earnings report since… Read More
Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering.… Read More
Smartsheet, the Seattle-area maker of work collaboration software, appointed Anna Griffin as its first chief marketing officer. Griffin was previously… Read More
Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition… Read More
Seattle-based biotech company Adaptive Biotechnologies announced Friday that the FDA has cleared its clonoSEQ platform for use. It marks first time a technology… Read More
